Scott Fletcher

Scott Fletcher has extensive work experience in various leadership roles within the pharmaceutical and analytical industries.

Currently, Scott serves as the Chief Executive Officer at RwHealth since February 2023. Before that, they worked as the Vice President at Element Materials Technology from July 2022 to October 2022.

From February 2020 to July 2022, Scott was the Chief Executive Officer at Arch Sciences Group. Prior to that, they held the position of Group Chief Executive Officer at CRAWFORD SCIENTIFIC HOLDINGS LIMITED from October 2019 to February 2020.

Scott has a long history with Crawford Scientific Ltd, where they started as a Training and Technical Consultant in February 2008. Over the years, they held several roles within the company, including Technical Development Leader from March 2010 to January 2011, Technical Business Development Manager from January 2011 to January 2016, and Director of Analytical Services from February 2016 to February 2020.

Between February 2016 and September 2019, Scott also worked as the Managing Director and Director of Analytical Services at HALL ANALYTICAL LABORATORIES LIMITED.

Scott's earlier work experience includes roles such as Senior Scientist at sanofi-aventis from January 2006 to February 2008, Senior Analyst at SAFC from March 2005 to January 2006, Senior Pharmaceutical Scientist at Cardinal Health from March 2003 to March 2005, and Pharmaceutical Scientist at Quality Control North West from August 2000 to March 2003.

Overall, Scott Fletcher has a diverse background in leadership, analytical services, and pharmaceutical development, making him a seasoned professional in the field.

Scott Fletcher attended Nottingham Trent University from 1996 to 2000, where they earned a Bachelor of Science (B.Sc.) degree in Chemistry. In March 2021, they obtained the certification as a Fellow of the Royal Society of Chemistry from the Royal Society of Chemistry.